||||||UI Path|
Conferences

Bio 14

Jun 17, 2014 Mountain View, CA

Systems of life are being harnessed for progress much as digital systems have been for the last 50 years. That progress isn’t affecting just health and drug development, it’s revolutionizing food and agriculture, energy, even manufacturing. Our first Techonomy Bio event aims to help all of us to understand how progress in bio and life sciences will change society and business.

New sources of energy, disease fighting bacteria, genetic road maps, synthetic foods, pollution detecting organisms, growing products, personal cancer cures, personalized anything cures, changing one’s DNA, reversing extinction, extending life – all are possibilities.

Come join Stewart Brand of the Long Now Foundation, Drew Endy of Stanford University, Jim Flatt of Synthetic Bio, Andrew Hessel of Autodesk, Ellen Jorgensen of Genspace, Eri Gentry of the Institute for the Future, Floyd Romesberg of Scripps, Beth Seidenberg of Kleiner Perkins Caufield & Byers, Steve Jurvetson of Draper Fisher Jurvetson and others for a half day conversation about technology’s impact on the rapidly accelerating, world changing progress in bio and life sciences.

All Sessions

Play all 9 sessions

Agenda

1:00 pm

Registration Opens

1:30 - 1:35 pm

Welcome

David Kirkpatrick

Founder and Editor-in-Chief, Techonomy

1:35 - 1:50 pm

Better, Faster, Cheaper

To beat cancer we need more targeted drugs, made faster, made cheaper. And that means we need to fix the way cancer drugs are made. Here's how. Presentation by:

Andrew Hessel

Distinguished Research Scientist, Autodesk

1:50 - 2:20 pm

How Will Biological Progress Transform the World?

With advances in biological and genomic sciences accelerating at an ever-increasing pace, what does the future hold? If biological progress is indeed advancing more rapidly than Moore’s Law, as many assert, what are the economic and societal implications?

Drew Endy

Associate Professor, Bioengineering, Stanford University

Alex Lash

National Biotechnology Editor, Xconomy

2:20 - 2:55 pm

Participatory Biology

Just as the Internet leveled the playing field for entrepreneurship, politics and social engagement, recent advances are leveling it for biological progress. Processing power, the cloud and Internet connectivity open doors for inquisitive individuals and nascent biotech startups. How are ordinary people involving themselves in biology, and what will be their impact?

Ryan Bethencourt

Program Director and Venture Partner, Indie.Bio

Eri Gentry

Technology Horizons Research Manager, Institute for the Future

David Haussler

Director, Center for Biomolecular Science and Engineering, UC Santa Cruz

David Kirkpatrick

Founder and Editor-in-Chief, Techonomy

2:55 - 3:00 pm
3:00 - 3:15 pm

A Life in Bio

180 seconds to turn 180 degrees. Reimagine. Reconsider. Rethink.

David Kirkpatrick

Founder and Editor-in-Chief, Techonomy

3:15 - 3:50 pm

The Funding Dilemma

Bio-innovators and entrepreneurs are often frustrated that investors don’t see the scope of biological opportunity. The industry's funding models remain in flux. With appetite for risk unpredictable and a landscape that’s often unexplored, what’s a startup to do? How are big companies responding?

Lindy Fishburne

Executive Director, Breakout Labs

3:50 - 3:55 pm

The Razor's Edge

How knife edge scanning helps drive bio discovery.
Presentation by:

Todd Huffman

Chief Executive Officer, 3Scan

3:55 - 4:25 pm

Programmable Life

Synthetic biology opens new doors on what life can be, and do. How will we utilize the awesome new tools at our disposal?

Ellen Jorgensen

Co-founder and Executive Director, Genspace

Ryan Phelan

Executive Director and Co-founder, Revive & Restore

Andrew Hessel

Distinguished Research Scientist, Autodesk

4:25 - 4:35 pm

Engineering Biology to Address Global Challenges

A look at the economic, social and regulatory implications.
Presentation by:

4:35 - 5:25 pm

Systems of Life Impact Business and Society

Exploration, experimentation and innovation. All fabulous pursuits in their own rights, but what about real-world application? From food to fuel, what are people doing with all these new bio discoveries

Stewart Brand

Co-founder, Global Business Network

Jim Flatt

President, Genovia Bio, Synthetic Genomics, Inc.

Steve Levine

Chief Strategy Officer, Dassault Systèmes

Floyd Romesberg

Associate Professor, Chemistry, The Scripps Research Institute

David Kirkpatrick

Founder and Editor-in-Chief, Techonomy

5:25 - 5:30 pm

Closing Remarks

David Kirkpatrick

Founder and Editor-in-Chief, Techonomy

5:30 - 6:00 pm

Reception

Sponsors

Presenting Partners

Media Partner

Partners

Hahn Auditorium

Address

1401 N Shoreline Blvd, Mountain View, CA, USA

Get Directions
Scroll to Top